Want to see IN:KRONOX full AI Analyst Report?
Kronox Lab Sciences Limited (KRONOX) AI Stock Analysis
Top Page
Kronox Lab Sciences Limited
(NSE:KRONOX)
Overall score reflects strong financial quality (high profitability, low leverage, solid free cash flow) and a clear positive technical trend (price above major moving averages with supportive momentum). The main constraint is valuation, with a higher P/E and minimal dividend yield, plus some caution from the latest-year cash flow decline.
Kronox Lab Sciences Limited (KRONOX) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 7.05B
- Dividend Yield
- 0.27%
- Average Volume (3M)
- 62.11K
- Price to Earnings (P/E)
- 24.1
- Beta (1Y)
- 1.23
- Revenue Growth
- 6.07%
- EPS Growth
- 11.62%
- Country
- India
- Employees
- 70
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Kronox Lab Sciences Limited Business Overview & Revenue Model
Company Description
Kronox Lab Sciences Ltd. operates as a manufacturer and global supplier of a diverse range of chemical products, encompassing fine chemicals, inorganic compounds, phosphates, and metallic chemicals, serving markets both within India and worldwide. It...
Kronox Lab Sciences Limited Financial Statement Overview
Summary
Strong profitability and margins with net income rising (FY2026: 276.6m vs FY2025: 254.7m), a conservatively levered balance sheet (very low debt vs equity), and solid free cash flow generation. Offsets include declining operating/free cash flow in FY2026 and unclear growth consistency due to conflicting revenue growth signals.
Income Statement
86Very PositiveBalance Sheet
83Very PositiveCash Flow
78Positive| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 992.88M | 1.01B | 898.62M | 1.00B | 955.78M | 822.47M |
| Gross Profit | 499.82M | 546.44M | 440.05M | 492.71M | 406.96M | 348.47M |
| EBITDA | 358.54M | 394.65M | 298.97M | 356.53M | 239.16M | 207.89M |
| Net Income | 255.96M | 276.60M | 213.51M | 254.67M | 166.17M | 136.27M |
Balance Sheet | ||||||
| Total Assets | 0 | 1.28B | 739.94M | 988.26M | 540.34M | 567.88M |
| Cash, Cash Equivalents and Short-Term Investments | 358.73M | 487.41M | 149.18M | 358.73M | 56.47M | 100.04M |
| Total Debt | 0 | 16.07M | 0 | 0 | 0 | 33.60M |
| Total Liabilities | -901.05M | 113.96M | 76.89M | 87.22M | 92.83M | 164.35M |
| Stockholders Equity | 901.05M | 1.16B | 663.05M | 901.05M | 446.79M | 403.53M |
Cash Flow | ||||||
| Free Cash Flow | 155.63M | 205.85M | 51.45M | 275.92M | 112.50M | 52.24M |
| Operating Cash Flow | 164.11M | 238.93M | 174.15M | 306.97M | 196.65M | 90.20M |
| Investing Cash Flow | -155.27M | -238.20M | -173.12M | -283.94M | -55.17M | -75.99M |
| Financing Cash Flow | 17.00K | -3.62M | 0 | -18.54M | -133.96M | -6.66M |
Kronox Lab Sciences Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRONOX, the sentiment is Neutral. The current price of 188.10 is below the 20-day moving average (MA) of 201.19, below the 50-day MA of 192.11, and above the 200-day MA of 148.87, indicating a neutral trend. The MACD of -0.11 indicates Positive momentum. The RSI at 44.35 is Neutral, neither overbought nor oversold. The STOCH value of 36.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:KRONOX.
Kronox Lab Sciences Limited Peers Comparison
Overall Rating
- IN:KRONOX79Outperform
IN:DICIND76Outperform
IN:CHEMBOND61Neutral
IN:PODDARMENT60Neutral
IN:ASAHISONG59Neutral
IN:MANORG38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:KRONOX | 79Outperform | INR 6.98B | 24.06 | ― | 0.27% | 6.07% | 11.62% |
| IN:DICIND | 76Outperform | INR 4.99B | 16.36 | ― | 0.55% | 11.71% | 79.88% |
| IN:CHEMBOND | 61Neutral | INR 2.38B | 15.88 | ― | 1.12% | 0.83% | -34.03% |
| IN:PODDARMENT | 60Neutral | INR 2.79B | 18.11 | ― | 1.53% | 3.55% | -21.35% |
| IN:ASAHISONG | 59Neutral | INR 4.36B | 12.53 | ― | 0.41% | -0.60% | 96.35% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:MANORG | 38Underperform | INR 3.81B | 18.59 | ― | ― | 17.28% | -10.19% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:KRONOX | Kronox Lab Sciences Limited | 188.10 | 42.02 | 28.77% | |
| IN:ASAHISONG | Asahi Songwon Colors Ltd. | 370.00 | 86.70 | 30.60% | |
| IN:CHEMBOND | Chembond Chemicals Limited | 176.85 | 7.19 | 4.24% | |
| IN:DICIND | DIC India Limited | 544.00 | 28.87 | 5.60% | |
| IN:MANORG | Mangalam Organics Ltd | 445.00 | -66.40 | -12.98% | |
| IN:PODDARMENT | Poddar Pigments Limited | 262.80 | -8.53 | -3.14% |
Kronox Lab Sciences Limited Corporate Events
Kronox Lab Sciences Sets September Date for 17th AGM via Virtual Format
Kronox Lab Sciences Limited operates in the laboratory chemicals and scientific supplies sector, serving industrial and research clients through its portfolio of high-purity reagents and related lab products. The company is listed on both the Nationa...
Kronox Lab Sciences Sets September 16 AGM, Proposes Dividend and Cost Audit Pay
Kronox Lab Sciences Limited has scheduled its 17th Annual General Meeting for September 16, 2026, at 11:00 a.m., to be conducted via video conferencing and other audio-visual means in line with recent regulatory guidance. The company has circulated t...
Indo Borax launches open offer for public shareholders of Kronox Lab Sciences
Kronox Lab Sciences Limited has disclosed that it has received a public announcement for an open offer to its public shareholders, triggered under India’s takeover regulations. The offer is being made by Indo Borax & Chemicals Limited, toge...
Kronox Promoters Agree to Sell Majority Stake to Indo Borax
Promoters of Kronox Lab Sciences Limited have signed a share purchase agreement to sell 2,38,44,000 equity shares, representing about 64.26% of the company’s paid-up equity capital, to Indo Borax & Chemicals Limited, with Zenrock Chemicals...
Kronox Lab Sciences Publishes Q1 FY2026 Unaudited Results in Newspapers
Kronox Lab Sciences Limited has notified the National Stock Exchange of India and BSE that it has published its unaudited financial results for the quarter ended June 30, 2026 in the Indian Express and Financial Express newspapers. The disclosure, ma...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 26, 2026